Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes Biotech

The Future of Manufacturing: How Composites Will Transform Industries

by Team Lumida
July 7, 2024
in Biotech
Reading Time: 3 mins read
A A
0
The Future of Manufacturing: How Composites Will Transform Industries
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

  1. New manufacturing techniques make composites cheaper and more accessible.
  2. Composites promise lighter, stronger consumer products and advanced aerospace components.
  3. Major companies are testing composites to replace traditional metals.

What Happened?

New manufacturing techniques are making composites—materials made from a variety of fibers embedded in plastics—cheaper and more accessible. Historically, composites like carbon-fiber have been limited to high-cost applications such as aerospace due to their labor-intensive manufacturing process.

However, startups such as Arris Composites, 9T Labs, and Orbital Composites are revolutionizing production methods. These companies have developed processes to quickly and inexpensively create composite parts, enabling their use in a wide range of products from running shoes to aerospace components. For example, Arris’s technology is being tested by Airbus to replace metal brackets in planes, and Orbital Composites has contracts with the U.S. military for satellite and drone components.

Why It Matters?

This shift to composites could transform multiple industries. Composites offer lighter and stronger alternatives to metal, significantly impacting transportation, consumer electronics, and even military applications. Imagine lighter, more fuel-efficient vehicles, durable smartphones, and advanced aerospace components—all possible due to these new materials.

“Composites are often able to perform just as well as high-strength metal parts, but with a fraction of the weight,” says Jeff Sloan, publisher of Composites World. This transition also mitigates geopolitical risks tied to metal supply chains, such as those involving titanium from Russia and China. Companies like ST Engineering are already experimenting with composite bolts for airplanes, showing promising initial results.

What’s Next?

Expect more consumer products and industrial applications to incorporate composites. Short-term, you’ll see lighter and more durable consumer electronics and advanced military hardware. Long-term, the automotive and aerospace industries will likely see the most significant transformations, reducing weight and improving efficiency.

Arris is in talks to use composites in virtual reality headsets, and 9T Labs is eyeing bicycle manufacturing. However, widespread adoption will depend on overcoming consumer perceptions associating metal with quality and proving long-term durability through rigorous testing. Investors should watch for announcements from key players like Airbus and U.S. military contractors, as these will signal broader market adoption and potential investment opportunities.

Source: WSJ
Tags: AerospaceCompositesManufacturing
Previous Post

S&P 500’s Big Earnings Test: Will Tech Slowdown Derail Gains?

Next Post

Web3 Goes Mobile: Valora’s Game-Changing Mobile Stack for iOS and Android

Recommended For You

U.S. Risks Losing Biotech Leadership to China, Congressional Report Warns

by Team Lumida
2 months ago
woman holding test tubes

Key Takeaways: Powered by lumidawealth.com A congressional commission has urged the U.S. to invest at least $15 billion in biotechnology research and manufacturing over the next five years to...

Read more

AstraZeneca Acquires EsoBiotec for $1 Billion to Strengthen Cell-Therapy Portfolio

by Team Lumida
3 months ago
vitamin b 12 100 mg

Key Takeaways: Powered by lumidawealth.com AstraZeneca will pay $425 million upfront, with an additional $575 million tied to milestones. The acquisition includes EsoBiotec’s innovative in vivo cell therapy platform....

Read more

Illumina Faces Mounting Challenges Amid Trade War, Competition, and Policy Shifts

by Team Lumida
3 months ago
Illumina Faces Mounting Challenges Amid Trade War, Competition, and Policy Shifts

Key Takeaways: Powered by lumidawealth.com Illumina’s stock has dropped over 25% this year, driven by trade tensions with China, NIH funding caps, and intensifying competition. China’s designation of Illumina...

Read more

New Oxford Study Links Ozempic to Dementia Prevention

by Team Lumida
11 months ago
New Oxford Study Links Ozempic to Dementia Prevention

Novo Nordisk's Ozempic has shown promising ancillary benefits beyond its primary use for diabetes and weight loss.

Read more

FDA Approves Lilly’s Kisunla for Alzheimer’s

by Team Lumida
11 months ago
shallow focus photography of white bottle lot

Eli Lilly & Co.’s new Alzheimer's treatment, Kisunla, has received FDA approval, becoming the second drug in the U.S. to slow the progression of Alzheimer's.

Read more

Revolutionary Al Model Foresees Dementia Years Ahead

by Team Lumida
12 months ago
an abstract image of a sphere with dots and lines

Researchers at Queen Mary University of London developed a new machine learning model that predicts dementia with over 80% accuracy up to nine years before diagnosis.

Read more

Biotech IPO Boom: What You Need to Know About 2024’s Hot Listings

by Team Lumida
12 months ago
woman holding test tubes

Alumis and Upstream Bio, US start-ups focused on developing treatments for inflammatory diseases, have filed for IPOs.

Read more

Direct Brain Delivery: Regeneration Bio’s Innovative Alzheimer’s Treatment Begins Testing

by Team Lumida
1 year ago
grandma, old woman, old age

Regeneration Biomedical has dosed the first patient in a Phase 1 clinical trial for RB-ADSC, its innovative stem cell therapy for mild-to-moderate Alzheimer’s disease.

Read more
Next Post
Web3 Goes Mobile: Valora’s Game-Changing Mobile Stack for iOS and Android

Web3 Goes Mobile: Valora's Game-Changing Mobile Stack for iOS and Android

$2.1 Trillion Private Credit Market Faces Major Risk: Are Investors Safe?

$2.1 Trillion Private Credit Market Faces Major Risk: Are Investors Safe?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Pure Storage Earnings Highlights: Double-Digit Growth and AI Opportunities

Pure Storage Earnings Highlights: Double-Digit Growth and AI Opportunities

August 29, 2024
man in green jacket standing beside white and blue van during daytime

FedEx Beats Wall Street Estimates: Is It Time to Buy?

June 26, 2024
a person is holding a blue credit card

Visa $V Q3 2024 Results

July 24, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018